Damae Medical
Damae Medical develops deepLive™, a medical imaging device that uses Line-field Confocal Optical Coherence Tomography (LC-OCT) for the non-invasive diagnosis of skin cancers such as melanoma and carcinoma. The system provides 3D cellular resolution imaging in situ, allowing dermatologists to switch between vertical histology-like and horizontal confocal-like views. The technology is designed to reduce unnecessary biopsies and improve early detection rates for clinical practitioners.
Visit websiteParis, France
Healthtech
Medtech
Medical Devices
Dermatology
Funding summary
- Total raised
- €7.0M
- Funding rounds
- 2
Investors in Damae Medical
Investors on record for Damae Medical. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Damae Medical?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors